Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...

Sales of blockbuster weight-loss drugs have surged in 2024 and are projected to continue rising in the coming years. The ...

Both Novo Nordisk and Eli Lilly are studying their weight loss drugs to treat fatty liver disease, chronic kidney disease, ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

When you weigh nearly 20 stone, small everyday things are fraught with anxiety. There are so many worries regular-sized ...

I have never felt more excited nor more of an irredeemable moral failure than I do right now. Over Christmas, my sister ...

Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

As we have entered into the new year 2025, here's a recap of 2024's economy and healthcare with key areas to look in global ...